Articles

  1. Aptuit Blister Packaging Case Study 4/28/2011
    A client, in need of global blister packaging, had received an exorbitant estimate from a Clinical Packaging and Logistics provider other than Aptuit.
  2. Mastering The Extended Clinical Supply Chain Whitepaper: Strategic Advantages For Clinical Trials 4/28/2011

    The core of any good clinical supply chain system is a supply management system that addresses all of the nuances of clinical supplies.

  3. Maximizing The Success Of Your CRO Partnerships Whitepaper 4/28/2011

    It’s certainly true that pharmaceutical companies are under intense pressure to replenish pipelines and reverse a trend in which R&D returns are falling below the costs of capital.

  4. Integrating Clinical Supply Systems & Outsourced Service Providers Whitepaper 4/28/2011

    Pharmaceutical and biotech companies of all sizes are increasingly turning to third parties to execute some or all of their clinical supply activities.

  5. Strong Collections Bring Robust Return 3/11/2011
    A US subsidiary of one of the top providers of branded and generic medications in India needs to improve collection performance on its accounts receivable (AR) for branded products. By DDN
  6. Special Handling Delivers US Launch 3/10/2011

    The manufacturer of a new pharmaceutical product with a pediatric indication has licensed the U.S. launch, storage, sales, and distribution to another company. By DDN

  7. Article: The 'Rogue' Biologist Speaks His Mind 3/6/2011
    Synthetic biology is one of the hottest and most rapidly growing new fields in life sciences. By Cliff Mintz Ph.D., Life Science Leader magazine
  8. Brochure: Custom Synthesis 12/6/2010

    PharmaZell draws upon a long history of successful custom synthesis projects, performed on a proprietary basis for pharmaceutical companies worldwide.

  9. The Scientific Path To Cycle Development 10/18/2010
    Management of medication delivery through lyophilization - freeze-drying - is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins and monoclonal antibodies, must be lyophilized as these therapeutic agents are insufficiently stable for ready-to-use solution dosage forms. By Baxter Healthcare Corporation -- BioPharma Solutions
  10. White Paper: The Scientific Path To Cycle Development 10/18/2010

    Management of medication delivery through lyophilization — freeze-drying — is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins, and monoclonal antibodies, must be lyophilized as these therapeutic agents are insufficiently stable for ready-to-use solution dosage forms. By Baxter Healthcare Corporation -- BioPharma Solutions